Barclays »

Bridgebio Pharma shares owned by Barclays

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 545k 25.46
2024-06-30 $11M 413k 25.33
2024-03-31 $15M 472k 30.92
2023-12-31 $30M 749k 40.37
2023-09-30 $13M 481k 26.37
2023-06-30 $10M 589k 17.20
2023-03-31 $11M 673k 16.58
2022-12-31 $9.2M 1.2M 7.62
2022-09-30 $3.2M 326k 9.94
2022-06-30 $268k 29k 9.10
2022-03-31 $432k 43k 10.15
2021-12-31 $3.2M 194k 16.68
2021-09-30 $4.2M 90k 46.86
2021-06-30 $3.8M 63k 60.96
2021-03-31 $6.2M 100k 61.61
2020-12-31 $2.6M 36k 71.12
2020-09-30 $1.3M 33k 37.52
2020-06-30 $1.5M 46k 32.61
2020-03-31 $851k 29k 28.99
2019-12-31 $916k 26k 35.06
2019-09-30 $294k 14k 21.46
2019-06-30 $467k 17k 26.94